| scholarly article | Q13442814 |
| P50 | author | Sara Gandini | Q51845664 |
| Aliana Guerrieri Gonzaga | Q73008383 | ||
| P Magni | Q73056695 | ||
| Massimiliano Ruscica | Q39688513 | ||
| P2093 | author name string | Bernardo Bonanni | |
| Franca Formelli | |||
| Andrea Decensi | |||
| Simona Iodice | |||
| Harriet Johansson | |||
| Marcella Gulisano | |||
| P2860 | cites work | Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. | Q51463161 |
| Insulin resistance and breast-cancer risk | Q54259823 | ||
| Energy balance, insulin resistance biomarkers, and breast cancer risk. | Q55474697 | ||
| Increased prevalence of prior breast cancer in women with newly diagnosed diabetes | Q60595426 | ||
| Long-term tolerability of fenretinide (4-HPR) in breast cancer patients | Q67904678 | ||
| The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women | Q71825679 | ||
| Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer | Q73358697 | ||
| Delayed severe hypertriglyceridemia from tamoxifen | Q73524655 | ||
| Retinol binding protein as a surrogate measure for serum retinol: studies in vitamin A-deficient children from the Republic of the Marshall Islands | Q73585715 | ||
| Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery | Q74184152 | ||
| Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 | ||
| Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects | Q79759732 | ||
| Tolerability of the synthetic retinoid Fenretinide (HPR) | Q93512087 | ||
| Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients | Q93521069 | ||
| Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer | Q28238331 | ||
| Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations | Q28264846 | ||
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
| Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy | Q28300092 | ||
| Western nutrition and the insulin resistance syndrome: a link to breast cancer | Q33547366 | ||
| Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer | Q33765709 | ||
| Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial | Q33937093 | ||
| Tamoxifen-induced severe hypertriglyceridemia and pancreatitis. | Q34064360 | ||
| Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. | Q34392166 | ||
| Molecular links between obesity and breast cancer | Q34530905 | ||
| Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 | ||
| Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression | Q36885845 | ||
| Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer | Q36918192 | ||
| Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors | Q38345749 | ||
| Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors | Q38357353 | ||
| Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development | Q38360743 | ||
| Distribution of fenretinide in the mammary gland of breast cancer patients | Q38534184 | ||
| Tamoxifen therapy for breast cancer and endometrial cancer risk. | Q41694508 | ||
| Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells | Q42440477 | ||
| Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins | Q42516031 | ||
| High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome | Q43815284 | ||
| Inhibition of glucose-induced electrical activity by 4-hydroxytamoxifen in rat pancreatic beta-cells | Q43826569 | ||
| A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers | Q44463946 | ||
| Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition | Q44541096 | ||
| Differential effects of leptin on cancer in vitro | Q44895551 | ||
| Endogenous sex hormones and subsequent breast cancer in premenopausal women | Q45047695 | ||
| Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). | Q46428394 | ||
| Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). | Q46495873 | ||
| Functional role of RXRs and PPARgamma in mature adipocytes. | Q46528965 | ||
| Influence of age on the association of retinol-binding protein 4 with metabolic syndrome | Q46779329 | ||
| Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women. | Q46871181 | ||
| Metabolic syndrome as a prognostic factor for breast cancer recurrences | Q46922126 | ||
| Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. | Q50864806 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tamoxifen | Q412178 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 9512-9518 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer | |
| P478 | volume | 68 |
| Q92091998 | A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors |
| Q35558983 | Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study |
| Q28534795 | Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients |
| Q93152835 | Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer |
| Q34334262 | Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial. |
| Q47246053 | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). |
| Q33923490 | Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro |
| Q36006997 | Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis |
| Q51005071 | Fenretinide prevents obesity in aged female mice in association with increased retinoid and estrogen signaling. |
| Q36635330 | Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamus. |
| Q36547331 | GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells |
| Q57287654 | Immune cells in the tumor: new roads of retinoids for chemoprevention and chemotherapeutics |
| Q37180380 | Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity |
| Q34557490 | Intervening on the side effects of hormone-dependent cancer treatment: the role of strength training. |
| Q39671678 | Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells |
| Q37474455 | Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis |
| Q39986644 | Metformin, insulin, breast cancer and more... |
| Q26861403 | Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells |
| Q37845832 | Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors |
| Q64074583 | Potential therapeutic targets for atherosclerosis in sphingolipid metabolism |
| Q35665099 | Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. |
| Q35762679 | Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay |
| Q90293197 | RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women |
| Q36570962 | Retinol as a cofactor for PKCδ-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity |
| Q26767191 | Retinol as electron carrier in redox signaling, a new frontier in vitamin A research |
| Q35478457 | Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis |
| Q39129668 | The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights. |
| Q35532291 | Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice |
| Q36117484 | Two protein kinase C isoforms, δ and ε, regulate energy homeostasis in mitochondria by transmitting opposing signals to the pyruvate dehydrogenase complex |
| Q39199843 | Vitamin A as PKC Co-factor and Regulator of Mitochondrial Energetics |
Search more.